)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Genomtec
Genomtec (GMT) investor relations material
Genomtec Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary28 Nov, 2025
Executive summary
Focus on R&D in molecular diagnostics, with Genomtec ID and OncoSNAAT as flagship projects.
No significant revenue from product sales; income mainly from grants and one-off orders.
Strategic goal is commercialization via partnerships, licensing, or technology sale.
Company listed on Warsaw Stock Exchange since February 2023.
Financial highlights
Revenue from sales for 9M 2025: PLN 15,000 vs. PLN 1,000 year-over-year.
Net loss for 9M 2025: PLN -9,127,000 vs. PLN -9,326,000 year-over-year.
R&D expenses increased to PLN 5,734,000 from PLN 1,912,000 year-over-year.
Cash and equivalents at 30.09.2025: PLN 7,402,000.
Equity at 30.09.2025: PLN 10,348,000.
Outlook and guidance
No financial forecasts published.
Commercialization of Genomtec ID and OncoSNAAT expected in coming years, pending successful partnerships.
Future results depend on securing further grants, investor funding, and successful product launches.
Genomtec ID commercialization path decision?
Impact of new subsidiaries on R&D focus?
Current cash runway after P series emission?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genomtec
- Rapid genetic diagnostics, strong IP, and robust funding drive growth and M&A momentum.GMT
Investor Presentation13 Nov 2025 - Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead.GMTQ2 202529 Sep 2025
- Qualified audit opinion issued due to uncertainty over development asset impairment.GMTQ4 202424 Jun 2025
- M&A advances with major cost cuts and tech progress, but no financial data disclosed.GMTInvestor Update13 Jun 2025
- Losses persist as Genomtec advances R&D, secures funding, and pursues M&A for commercialisation.GMTQ3 202413 Jun 2025
- Net loss widened to PLN 6.0 million in H1 2024 as Genomtec advanced R&D and raised new capital.GMTQ2 202413 Jun 2025
- Genomtec's Q1 2025 loss widened as R&D ramped up, with commercialization still pending.GMTQ1 20256 Jun 2025
Next Genomtec earnings date
Q4 202530 Apr, 2026
Genomtec
Next Genomtec earnings date
Q4 202530 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage